Ayman O S Ei-Kadi (Ahmed A El-Sherbeni, Ayman O S El-Kadi)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Venues

Drug metabolism and disposition: the biological fate of chemicals

Drug metabolism reviews

Canadian journal of physiology and pharmacology

Drug development research

University of Alberta

University of Montreal (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Alberta Jul 01 2001

Canada

Professor and Associate Dean, Research :: Faculty of Pharmacy and Pharmaceutical Sciences

Education History

University of Montreal Jan 01 1995 - Jan 20 1999

Canada

PHD :: Pharmacology

Publications

Farag E S Mosa, Mohammed A Alqahtani, Mahmoud A El-Ghiaty, Jason R B Dyck, Khaled Barakat, Ayman O S Ei-Kadi
Identification of aryl hydrocarbon receptor allosteric antagonists from clinically approved drugs. Drug development research 85 (5) (2024)
Farag E S Mosa, Mohammed A Alqahtani, Mahmoud A El-Ghiaty, Jason R B Dyck, Khaled Barakat, Ayman O S Ei-Kadi
Identification of aryl hydrocarbon receptor allosteric antagonists from clinically approved drugs. Drug development research 85 (5) (2024)
Mohammed A W ElKhatib, Samar H Gerges, Fadumo A Isse, Ayman O S Ei-Kadi
Cytochrome P450 1B1 is critical in the development of TNF-α, IL-6, and LPS-induced cellular hypertrophy. Canadian journal of physiology and pharmacology (2024)
Ahmad H Alammari, Fadumo Ahmed Isse, Conor O'Croinin, Neal M Davies, Ayman O S Ei-Kadi
Modulation of Angiotensin II-Induced Cellular Hypertrophy by Cannflavin-C: Unveiling the Impact on Cytochrome P450 1B1 and Arachidonic Acid Metabolites . Drug metabolism and disposition: the biological fate of chemicals (2024)
Ahmad H Alammari, Fadumo Ahmed Isse, Conor O'Croinin, Neal M Davies, Ayman O S Ei-Kadi
Modulation of Angiotensin II-Induced Cellular Hypertrophy by Cannflavin-C: Unveiling the Impact on Cytochrome P450 1B1 and Arachidonic Acid Metabolites. Drug metabolism and disposition: the biological fate of chemicals 52 (8) (2024)
Mohammed A W ElKhatib, Samar H Gerges, Fadumo A Isse, Ayman O S Ei-Kadi
Cytochrome P450 1B1 is critical in the development of TNF-α, IL-6, and LPS-induced cellular hypertrophy. Canadian journal of physiology and pharmacology 102 (7) (2024)
Ahmad H Alammari, Fadumo Ahmed Isse, Conor O'Croinin, Neal M Davies, Ayman O S Ei-Kadi
Modulation of Angiotensin II-Induced Cellular Hypertrophy by Cannflavin-C: Unveiling the Impact on Cytochrome P450 1B1 and Arachidonic Acid Metabolites. Drug metabolism and disposition: the biological fate of chemicals 52 (8) (2024)
Mohammed A W ElKhatib, Samar H Gerges, Fadumo A Isse, Ayman O S Ei-Kadi
Cytochrome P450 1B1 is critical in the development of TNF-α, IL-6, and LPS-induced cellular hypertrophy. Canadian journal of physiology and pharmacology 102 (7) (2024)
Rahmat Hidayat, Mahmoud A El-Ghiaty, Sherif M Shoieb, Mohammed A Alqahtani, Ayman O S Ei-Kadi
The Effects of 16-HETE Enantiomers on Hypertrophic Markers in Human Fetal Ventricular Cardiomyocytes, RL-14 Cells. European journal of drug metabolism and pharmacokinetics (2023)
Sara A Helal, Samar H Gerges, Ayman O S Ei-Kadi
Enantioselectivity in some physiological and pathophysiological roles of hydroxyeicosatetraenoic acids. Drug metabolism reviews 56 (1) (2023)
Mahmoud A El-Ghiaty, Sara R El-Mahrouk, Mohammed A Alqahtani, Ayman O S Ei-Kadi
Differential modulation of cytochrome P450 enzymes by arsenicals in non-human experimental models. Drug metabolism reviews (2023)
Sara A Helal, Samar H Gerges, Ayman O S Ei-Kadi
Enantioselectivity in some physiological and pathophysiological roles of hydroxyeicosatetraenoic acids. Drug metabolism reviews 56 (1) (2023)
Sara A Helal, Fadumo Ahmed Isse, Samar H Gerges, Ayman O S Ei-Kadi
Physiological and pathophysiological roles of hepoxilins and their analogs. Drug metabolism reviews (2023)
Ahmad H Alammari, Samar H Gerges, Fadumo Ahmed Isse, Ayman O S Ei-Kadi
6-Formylindolo[3,2-b]carbazole (FICZ) protects against angiotensin II-induced cellular hypertrophy through the induction of CYP1A1 and its associated 19(S)-HETE metabolite in vitro . Drug metabolism and disposition: the biological fate of chemicals (2023)
Mohammed A W ElKhatib, Fadumo Ahmed Isse, Ayman O S Ei-Kadi
Effect of inflammation on cytochrome P450-mediated arachidonic acid metabolism and the consequences on cardiac hypertrophy. Drug metabolism reviews (2022)
Sherif M Shoieb, Ahmad H Alammari, Jody Levasseur, Heidi Silver, Jason R B Dyck, Ayman O S Ei-Kadi
Ameliorative Role of Fluconazole Against Abdominal Aortic Constriction-Induced Cardiac Hypertrophy in Rats. Journal of cardiovascular pharmacology 79 (6) (2022)
Ahmed A El-Sherbeni, Rabia Bhatti, Fadumo A Isse, Ayman O S Ei-Kadi
Identifying simultaneous matrix metalloproteinases/soluble epoxide hydrolase inhibitors. Molecular and cellular biochemistry 477 (3) (2022)
Mohammed A Alqahtani, Mahmoud A El-Ghiaty, Ayman O S Ei-Kadi
Mercury and methylmercury differentially modulate hepatic cytochrome P450 1A1 and 1A2 in vivo and in vitro. Journal of biochemical and molecular toxicology (2022)
Samar H Gerges, Ayman O S Ei-Kadi
Sexual Dimorphism in the Expression of Cytochrome P450 Enzymes in Rat Heart, Liver, Kidney, Lung, Brain, and Small Intestine . Drug metabolism and disposition: the biological fate of chemicals (2022)
Mahmoud A El-Ghiaty, Ayman O S Ei-Kadi
Arsenic: Various species with different effects on cytochrome P450 regulation in humans. EXCLI journal 20 (2021)
Sherif M Shoieb, Rambabu Dakarapu, John R Falck, Ayman O S Ei-Kadi
Novel Synthetic Analogues of 19(S/R)-Hydroxyeicosatetraenoic Acid Exhibit Noncompetitive Inhibitory Effect on the Activity of Cytochrome P450 1A1 and 1B1. European journal of drug metabolism and pharmacokinetics 46 (5) (2021)
Sherif M Shoieb, Mahmoud A El-Ghiaty, Ayman O S Ei-Kadi
Targeting arachidonic acid-related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles. Emergent materials (2020)
Sherif M Shoieb, Ayman O S Ei-Kadi
Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites. Molecular and cellular biochemistry 471 (1-2) (2020)
Zaid H Maayah, Ghada Abdelhamid, Osama H Elshenawy, Ahmed A El-Sherbeni, Hassan N Althurwi, Erica McGinn, Doaa Dawood, Ahmad H Alammari, Ayman O S Ei-Kadi
The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity. Cardiovascular toxicology 18 (3) (2019)
Sherif M Shoieb, Ayman O S Ei-Kadi, Ayman O S El-Kadi
Identification of 19-(S/R)Hydroxyeicosatetraenoic Acid as the First Endogenous Noncompetitive Inhibitor of Cytochrome P450 1B1 with Enantioselective Activity. Drug metabolism and disposition: the biological fate of chemicals 47 (2) (2018)
Zaid H Maayah, Jody Levasseur, Ramanaguru Siva Piragasam, Ghada Abdelhamid, Jason R B Dyck, Richard P Fahlman, Arno G Siraki, Ayman O S Ei-Kadi
2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy. Scientific reports 8 (1) (2018)
Tomoko Endo, Victor Samokhvalov, Ahmed M Darwesh, Kevin M W Khey, Ahmed A El-Sherbeni, Ayman O S Ei-Kadi, Takuji Machida, Masahiko Hirafuji, John M Seubert
DHA and 19,20-EDP induce lysosomal-proteolytic-dependent cytotoxicity through de novo ceramide production in H9c2 cells with a glycolytic profile. Cell death discovery 4 (2018)

Ayman O S Ei-Kadi.css-eqlu8i{font-size:small;padding-left:4px;} (Ahmed A El-Sherbeni, Ayman O S El-Kadi)

Publication Activity (10 Years)

Top Topics

Top Venues

Ayman O S Ei-Kadi (Ahmed A El-Sherbeni, Ayman O S El-Kadi)